Analyst Sees Multi-Billion-Dollar Sales Potential for Zura Bio’s Lead Therapy

4 hours ago

On Wednesday, William Blair initiated coverage of Zura Bio Limited (NASDAQ:ZURA) with an Outperform rating, citing the potential of its lead …